Global Blood Glucose Testing research

Blood Glucose Testing Comprehensive Study by Type (Blood Glucose Meters, Continuous Glucose Monitoring Systems {Sensors, Transmitter}, Glucose Monitoring Strips, Lancets), Diabetes Type (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes), End-User (Hospital & Clinics, Diagnostic Centre, Home Care, Others) Players and Region - Global Market Outlook to 2028

Blood Glucose Testing Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Blood Glucose Testing Market Scope
Blood glucose testing is the process of measuring the concentration of glucose (sugar) in a person's blood. It is commonly performed by individuals with diabetes to monitor their blood sugar levels and make informed decisions about their diabetes management, including medication, diet, and lifestyle adjustments. It can be carried out anywhere at home using a blood glucose meter. The blood glucose testing market is expanding in emerging markets, driven by the increasing prevalence of diabetes, improving healthcare infrastructure.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledMedtronic (Ireland), Menarini Diagnostics (Italy), Abaxis (United States), Abbott Laboratories (United States), ACON Laboratories, Inc. (United States), AgaMatrix (Germany), Bayer (Germany), Bio-Rad (United States), Roche (Switzerland) and LifeScan (United States)
CAGR%


The global blood glucose testing market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensify their market share and escalation their profitability. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Blood Glucose Testing market throughout the predicted period.

Medtronic (Ireland), Menarini Diagnostics (Italy), Abaxis (United States), Abbott Laboratories (United States), ACON Laboratories, Inc. (United States), AgaMatrix (Germany), Bayer (Germany), Bio-Rad (United States), Roche (Switzerland) and LifeScan (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Ascensia (Switzerland), Dexcom (United States), Ypsomed (Switzerland) and B. Braun (Germany).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Blood Glucose Testing market by Type and Region with country level break-up.

On the basis of geography, the market of Blood Glucose Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
In May 2019, LifeScan, a blood glucose monitoring and maker of the iconic OneTouch® brand, announced it has entered into an agreement with Sanvita Medical, LLC, to market continuous glucose monitoring (CGM) sensors. Through this collaboration, the companies plan to launch CGM systems in North America and select countries in Europe as early as mid-next year and then expand into other markets around the world.
In April 2023, FDA Approves Medtronic MiniMed™ 780G System - World's First Insulin Pump with Meal Detection Technology* that provides automatic adjustments and corrections to sugar levels every 5 minutes and In November 2020, Abbott announced the FreeStyle Libre system, a continuous glucose monitoring (CGM) technology. It can be used by adults and children (above the age of four) as well as women with gestational diabetes (diabetes during pregnancy).
In the United States, the Food and Drug Administration (FDA) is responsible for regulating medical devices, including blood glucose testing devices. The FDA ensures that these devices meet safety and effectiveness standards before they can be marketed and sold in the country. The FDA classifies blood glucose testing equipment as a medical device and evaluates its functionality, labeling, and production methods.

Influencing Trend:
Technology Advancement in Glucose Monitoring Devices

Market Growth Drivers:
Growing Prevalence of Diabetes and Increasing Aging Population with Diabetes

Challenges:
Blood Glucose Testing Devices are Subject to Stringent Regulatory Requirements to Ensure Their Safety, Accuracy, and Reliability

Restraints:
High Cost Associated with Blood GlucoseTesting Devices

Opportunities:
Rise in Diabetic Population Presents an Opportunity for Manufacturers to Develop and Market Innovative Testing Devices

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Blood Glucose Testing Service Providers, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Report Objectives / Segmentation Covered

By Type
  • Blood Glucose Meters
  • Continuous Glucose Monitoring Systems {Sensors, Transmitter}
  • Glucose Monitoring Strips
  • Lancets
By Diabetes Type
  • Type 2 Diabetes
  • Type 1 Diabetes
  • Gestational Diabetes

By End-User
  • Hospital & Clinics
  • Diagnostic Centre
  • Home Care
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Diabetes
      • 3.2.2. Increasing Aging Population with Diabetes
    • 3.3. Market Challenges
      • 3.3.1. Blood Glucose Testing Devices are Subject to Stringent Regulatory Requirements to Ensure Their Safety, Accuracy, and Reliability
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Glucose Monitoring Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Glucose Testing, by Type, Diabetes Type, End-User and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Blood Glucose Testing (Value)
      • 5.2.1. Global Blood Glucose Testing by: Type (Value)
        • 5.2.1.1. Blood Glucose Meters
        • 5.2.1.2. Continuous Glucose Monitoring Systems {Sensors, Transmitter}
        • 5.2.1.3. Glucose Monitoring Strips
        • 5.2.1.4. Lancets
      • 5.2.2. Global Blood Glucose Testing by: Diabetes Type (Value)
        • 5.2.2.1. Type 2 Diabetes
        • 5.2.2.2. Type 1 Diabetes
        • 5.2.2.3. Gestational Diabetes
      • 5.2.3. Global Blood Glucose Testing by: End-User (Value)
        • 5.2.3.1. Hospital & Clinics
        • 5.2.3.2. Diagnostic Centre
        • 5.2.3.3. Home Care
        • 5.2.3.4. Others
      • 5.2.4. Global Blood Glucose Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Blood Glucose Testing (Volume)
      • 5.3.1. Global Blood Glucose Testing by: Type (Volume)
        • 5.3.1.1. Blood Glucose Meters
        • 5.3.1.2. Continuous Glucose Monitoring Systems {Sensors, Transmitter}
        • 5.3.1.3. Glucose Monitoring Strips
        • 5.3.1.4. Lancets
      • 5.3.2. Global Blood Glucose Testing by: Diabetes Type (Volume)
        • 5.3.2.1. Type 2 Diabetes
        • 5.3.2.2. Type 1 Diabetes
        • 5.3.2.3. Gestational Diabetes
      • 5.3.3. Global Blood Glucose Testing by: End-User (Volume)
        • 5.3.3.1. Hospital & Clinics
        • 5.3.3.2. Diagnostic Centre
        • 5.3.3.3. Home Care
        • 5.3.3.4. Others
      • 5.3.4. Global Blood Glucose Testing Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Blood Glucose Testing (Price)
      • 5.4.1. Global Blood Glucose Testing by: Type (Price)
  • 6. Blood Glucose Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Menarini Diagnostics (Italy)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abaxis (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ACON Laboratories, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AgaMatrix (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bayer (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Rad (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Roche (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. LifeScan (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Glucose Testing Sale, by Type, Diabetes Type, End-User and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Blood Glucose Testing (Value)
      • 7.2.1. Global Blood Glucose Testing by: Type (Value)
        • 7.2.1.1. Blood Glucose Meters
        • 7.2.1.2. Continuous Glucose Monitoring Systems {Sensors, Transmitter}
        • 7.2.1.3. Glucose Monitoring Strips
        • 7.2.1.4. Lancets
      • 7.2.2. Global Blood Glucose Testing by: Diabetes Type (Value)
        • 7.2.2.1. Type 2 Diabetes
        • 7.2.2.2. Type 1 Diabetes
        • 7.2.2.3. Gestational Diabetes
      • 7.2.3. Global Blood Glucose Testing by: End-User (Value)
        • 7.2.3.1. Hospital & Clinics
        • 7.2.3.2. Diagnostic Centre
        • 7.2.3.3. Home Care
        • 7.2.3.4. Others
      • 7.2.4. Global Blood Glucose Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Blood Glucose Testing (Volume)
      • 7.3.1. Global Blood Glucose Testing by: Type (Volume)
        • 7.3.1.1. Blood Glucose Meters
        • 7.3.1.2. Continuous Glucose Monitoring Systems {Sensors, Transmitter}
        • 7.3.1.3. Glucose Monitoring Strips
        • 7.3.1.4. Lancets
      • 7.3.2. Global Blood Glucose Testing by: Diabetes Type (Volume)
        • 7.3.2.1. Type 2 Diabetes
        • 7.3.2.2. Type 1 Diabetes
        • 7.3.2.3. Gestational Diabetes
      • 7.3.3. Global Blood Glucose Testing by: End-User (Volume)
        • 7.3.3.1. Hospital & Clinics
        • 7.3.3.2. Diagnostic Centre
        • 7.3.3.3. Home Care
        • 7.3.3.4. Others
      • 7.3.4. Global Blood Glucose Testing Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Blood Glucose Testing (Price)
      • 7.4.1. Global Blood Glucose Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Glucose Testing: by Type(USD Million)
  • Table 2. Blood Glucose Testing Blood Glucose Meters , by Region USD Million (2017-2022)
  • Table 3. Blood Glucose Testing Continuous Glucose Monitoring Systems {Sensors, Transmitter} , by Region USD Million (2017-2022)
  • Table 4. Blood Glucose Testing Glucose Monitoring Strips , by Region USD Million (2017-2022)
  • Table 5. Blood Glucose Testing Lancets , by Region USD Million (2017-2022)
  • Table 6. Blood Glucose Testing: by Diabetes Type(USD Million)
  • Table 7. Blood Glucose Testing Type 2 Diabetes , by Region USD Million (2017-2022)
  • Table 8. Blood Glucose Testing Type 1 Diabetes , by Region USD Million (2017-2022)
  • Table 9. Blood Glucose Testing Gestational Diabetes , by Region USD Million (2017-2022)
  • Table 10. Blood Glucose Testing: by End-User(USD Million)
  • Table 11. Blood Glucose Testing Hospital & Clinics , by Region USD Million (2017-2022)
  • Table 12. Blood Glucose Testing Diagnostic Centre , by Region USD Million (2017-2022)
  • Table 13. Blood Glucose Testing Home Care , by Region USD Million (2017-2022)
  • Table 14. Blood Glucose Testing Others , by Region USD Million (2017-2022)
  • Table 15. South America Blood Glucose Testing, by Country USD Million (2017-2022)
  • Table 16. South America Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 17. South America Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 18. South America Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 19. Brazil Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 20. Brazil Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 21. Brazil Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 22. Argentina Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 23. Argentina Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 24. Argentina Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 25. Rest of South America Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 26. Rest of South America Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 27. Rest of South America Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 28. Asia Pacific Blood Glucose Testing, by Country USD Million (2017-2022)
  • Table 29. Asia Pacific Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 30. Asia Pacific Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 31. Asia Pacific Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 32. China Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 33. China Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 34. China Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 35. Japan Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 36. Japan Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 37. Japan Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 38. India Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 39. India Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 40. India Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 41. South Korea Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 42. South Korea Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 43. South Korea Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 44. Taiwan Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 45. Taiwan Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 46. Taiwan Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 47. Australia Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 48. Australia Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 49. Australia Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 53. Europe Blood Glucose Testing, by Country USD Million (2017-2022)
  • Table 54. Europe Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 55. Europe Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 56. Europe Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 57. Germany Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 58. Germany Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 59. Germany Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 60. France Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 61. France Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 62. France Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 63. Italy Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 64. Italy Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 65. Italy Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 66. United Kingdom Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 67. United Kingdom Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 68. United Kingdom Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 69. Netherlands Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 70. Netherlands Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 71. Netherlands Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 72. Rest of Europe Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 73. Rest of Europe Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 74. Rest of Europe Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 75. MEA Blood Glucose Testing, by Country USD Million (2017-2022)
  • Table 76. MEA Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 77. MEA Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 78. MEA Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 79. Middle East Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 80. Middle East Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 81. Middle East Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 82. Africa Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 83. Africa Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 84. Africa Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 85. North America Blood Glucose Testing, by Country USD Million (2017-2022)
  • Table 86. North America Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 87. North America Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 88. North America Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 89. United States Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 90. United States Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 91. United States Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 92. Canada Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 93. Canada Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 94. Canada Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 95. Mexico Blood Glucose Testing, by Type USD Million (2017-2022)
  • Table 96. Mexico Blood Glucose Testing, by Diabetes Type USD Million (2017-2022)
  • Table 97. Mexico Blood Glucose Testing, by End-User USD Million (2017-2022)
  • Table 98. Blood Glucose Testing Sales: by Type(K Units)
  • Table 99. Blood Glucose Testing Sales Blood Glucose Meters , by Region K Units (2017-2022)
  • Table 100. Blood Glucose Testing Sales Continuous Glucose Monitoring Systems {Sensors, Transmitter} , by Region K Units (2017-2022)
  • Table 101. Blood Glucose Testing Sales Glucose Monitoring Strips , by Region K Units (2017-2022)
  • Table 102. Blood Glucose Testing Sales Lancets , by Region K Units (2017-2022)
  • Table 103. Blood Glucose Testing Sales: by Diabetes Type(K Units)
  • Table 104. Blood Glucose Testing Sales Type 2 Diabetes , by Region K Units (2017-2022)
  • Table 105. Blood Glucose Testing Sales Type 1 Diabetes , by Region K Units (2017-2022)
  • Table 106. Blood Glucose Testing Sales Gestational Diabetes , by Region K Units (2017-2022)
  • Table 107. Blood Glucose Testing Sales: by End-User(K Units)
  • Table 108. Blood Glucose Testing Sales Hospital & Clinics , by Region K Units (2017-2022)
  • Table 109. Blood Glucose Testing Sales Diagnostic Centre , by Region K Units (2017-2022)
  • Table 110. Blood Glucose Testing Sales Home Care , by Region K Units (2017-2022)
  • Table 111. Blood Glucose Testing Sales Others , by Region K Units (2017-2022)
  • Table 112. South America Blood Glucose Testing Sales, by Country K Units (2017-2022)
  • Table 113. South America Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 114. South America Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 115. South America Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 116. Brazil Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 117. Brazil Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 118. Brazil Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 119. Argentina Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 120. Argentina Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 121. Argentina Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 122. Rest of South America Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 123. Rest of South America Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 124. Rest of South America Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 125. Asia Pacific Blood Glucose Testing Sales, by Country K Units (2017-2022)
  • Table 126. Asia Pacific Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 127. Asia Pacific Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 128. Asia Pacific Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 129. China Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 130. China Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 131. China Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 132. Japan Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 133. Japan Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 134. Japan Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 135. India Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 136. India Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 137. India Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 138. South Korea Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 139. South Korea Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 140. South Korea Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 141. Taiwan Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 142. Taiwan Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 143. Taiwan Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 144. Australia Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 145. Australia Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 146. Australia Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 147. Rest of Asia-Pacific Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 148. Rest of Asia-Pacific Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 149. Rest of Asia-Pacific Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 150. Europe Blood Glucose Testing Sales, by Country K Units (2017-2022)
  • Table 151. Europe Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 152. Europe Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 153. Europe Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 154. Germany Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 155. Germany Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 156. Germany Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 157. France Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 158. France Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 159. France Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 160. Italy Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 161. Italy Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 162. Italy Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 163. United Kingdom Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 164. United Kingdom Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 165. United Kingdom Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 166. Netherlands Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 167. Netherlands Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 168. Netherlands Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 169. Rest of Europe Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 170. Rest of Europe Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 171. Rest of Europe Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 172. MEA Blood Glucose Testing Sales, by Country K Units (2017-2022)
  • Table 173. MEA Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 174. MEA Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 175. MEA Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 176. Middle East Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 177. Middle East Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 178. Middle East Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 179. Africa Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 180. Africa Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 181. Africa Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 182. North America Blood Glucose Testing Sales, by Country K Units (2017-2022)
  • Table 183. North America Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 184. North America Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 185. North America Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 186. United States Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 187. United States Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 188. United States Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 189. Canada Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 190. Canada Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 191. Canada Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 192. Mexico Blood Glucose Testing Sales, by Type K Units (2017-2022)
  • Table 193. Mexico Blood Glucose Testing Sales, by Diabetes Type K Units (2017-2022)
  • Table 194. Mexico Blood Glucose Testing Sales, by End-User K Units (2017-2022)
  • Table 195. Blood Glucose Testing: by Type(USD/Units)
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Blood Glucose Testing: by Type(USD Million)
  • Table 207. Blood Glucose Testing Blood Glucose Meters , by Region USD Million (2023-2028)
  • Table 208. Blood Glucose Testing Continuous Glucose Monitoring Systems {Sensors, Transmitter} , by Region USD Million (2023-2028)
  • Table 209. Blood Glucose Testing Glucose Monitoring Strips , by Region USD Million (2023-2028)
  • Table 210. Blood Glucose Testing Lancets , by Region USD Million (2023-2028)
  • Table 211. Blood Glucose Testing: by Diabetes Type(USD Million)
  • Table 212. Blood Glucose Testing Type 2 Diabetes , by Region USD Million (2023-2028)
  • Table 213. Blood Glucose Testing Type 1 Diabetes , by Region USD Million (2023-2028)
  • Table 214. Blood Glucose Testing Gestational Diabetes , by Region USD Million (2023-2028)
  • Table 215. Blood Glucose Testing: by End-User(USD Million)
  • Table 216. Blood Glucose Testing Hospital & Clinics , by Region USD Million (2023-2028)
  • Table 217. Blood Glucose Testing Diagnostic Centre , by Region USD Million (2023-2028)
  • Table 218. Blood Glucose Testing Home Care , by Region USD Million (2023-2028)
  • Table 219. Blood Glucose Testing Others , by Region USD Million (2023-2028)
  • Table 220. South America Blood Glucose Testing, by Country USD Million (2023-2028)
  • Table 221. South America Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 222. South America Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 223. South America Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 224. Brazil Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 225. Brazil Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 226. Brazil Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 227. Argentina Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 228. Argentina Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 229. Argentina Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 230. Rest of South America Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 231. Rest of South America Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 232. Rest of South America Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 233. Asia Pacific Blood Glucose Testing, by Country USD Million (2023-2028)
  • Table 234. Asia Pacific Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 235. Asia Pacific Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 236. Asia Pacific Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 237. China Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 238. China Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 239. China Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 240. Japan Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 241. Japan Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 242. Japan Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 243. India Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 244. India Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 245. India Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 246. South Korea Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 247. South Korea Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 248. South Korea Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 249. Taiwan Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 250. Taiwan Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 251. Taiwan Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 252. Australia Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 253. Australia Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 254. Australia Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 255. Rest of Asia-Pacific Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 256. Rest of Asia-Pacific Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 257. Rest of Asia-Pacific Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 258. Europe Blood Glucose Testing, by Country USD Million (2023-2028)
  • Table 259. Europe Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 260. Europe Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 261. Europe Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 262. Germany Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 263. Germany Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 264. Germany Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 265. France Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 266. France Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 267. France Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 268. Italy Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 269. Italy Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 270. Italy Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 271. United Kingdom Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 272. United Kingdom Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 273. United Kingdom Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 274. Netherlands Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 275. Netherlands Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 276. Netherlands Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 277. Rest of Europe Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 278. Rest of Europe Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 279. Rest of Europe Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 280. MEA Blood Glucose Testing, by Country USD Million (2023-2028)
  • Table 281. MEA Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 282. MEA Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 283. MEA Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 284. Middle East Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 285. Middle East Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 286. Middle East Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 287. Africa Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 288. Africa Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 289. Africa Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 290. North America Blood Glucose Testing, by Country USD Million (2023-2028)
  • Table 291. North America Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 292. North America Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 293. North America Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 294. United States Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 295. United States Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 296. United States Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 297. Canada Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 298. Canada Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 299. Canada Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 300. Mexico Blood Glucose Testing, by Type USD Million (2023-2028)
  • Table 301. Mexico Blood Glucose Testing, by Diabetes Type USD Million (2023-2028)
  • Table 302. Mexico Blood Glucose Testing, by End-User USD Million (2023-2028)
  • Table 303. Blood Glucose Testing Sales: by Type(K Units)
  • Table 304. Blood Glucose Testing Sales Blood Glucose Meters , by Region K Units (2023-2028)
  • Table 305. Blood Glucose Testing Sales Continuous Glucose Monitoring Systems {Sensors, Transmitter} , by Region K Units (2023-2028)
  • Table 306. Blood Glucose Testing Sales Glucose Monitoring Strips , by Region K Units (2023-2028)
  • Table 307. Blood Glucose Testing Sales Lancets , by Region K Units (2023-2028)
  • Table 308. Blood Glucose Testing Sales: by Diabetes Type(K Units)
  • Table 309. Blood Glucose Testing Sales Type 2 Diabetes , by Region K Units (2023-2028)
  • Table 310. Blood Glucose Testing Sales Type 1 Diabetes , by Region K Units (2023-2028)
  • Table 311. Blood Glucose Testing Sales Gestational Diabetes , by Region K Units (2023-2028)
  • Table 312. Blood Glucose Testing Sales: by End-User(K Units)
  • Table 313. Blood Glucose Testing Sales Hospital & Clinics , by Region K Units (2023-2028)
  • Table 314. Blood Glucose Testing Sales Diagnostic Centre , by Region K Units (2023-2028)
  • Table 315. Blood Glucose Testing Sales Home Care , by Region K Units (2023-2028)
  • Table 316. Blood Glucose Testing Sales Others , by Region K Units (2023-2028)
  • Table 317. South America Blood Glucose Testing Sales, by Country K Units (2023-2028)
  • Table 318. South America Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 319. South America Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 320. South America Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 321. Brazil Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 322. Brazil Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 323. Brazil Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 324. Argentina Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 325. Argentina Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 326. Argentina Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 327. Rest of South America Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 328. Rest of South America Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 329. Rest of South America Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 330. Asia Pacific Blood Glucose Testing Sales, by Country K Units (2023-2028)
  • Table 331. Asia Pacific Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 332. Asia Pacific Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 333. Asia Pacific Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 334. China Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 335. China Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 336. China Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 337. Japan Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 338. Japan Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 339. Japan Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 340. India Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 341. India Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 342. India Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 343. South Korea Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 344. South Korea Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 345. South Korea Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 346. Taiwan Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 347. Taiwan Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 348. Taiwan Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 349. Australia Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 350. Australia Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 351. Australia Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 352. Rest of Asia-Pacific Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 353. Rest of Asia-Pacific Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 354. Rest of Asia-Pacific Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 355. Europe Blood Glucose Testing Sales, by Country K Units (2023-2028)
  • Table 356. Europe Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 357. Europe Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 358. Europe Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 359. Germany Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 360. Germany Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 361. Germany Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 362. France Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 363. France Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 364. France Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 365. Italy Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 366. Italy Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 367. Italy Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 368. United Kingdom Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 369. United Kingdom Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 370. United Kingdom Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 371. Netherlands Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 372. Netherlands Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 373. Netherlands Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 374. Rest of Europe Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 375. Rest of Europe Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 376. Rest of Europe Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 377. MEA Blood Glucose Testing Sales, by Country K Units (2023-2028)
  • Table 378. MEA Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 379. MEA Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 380. MEA Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 381. Middle East Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 382. Middle East Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 383. Middle East Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 384. Africa Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 385. Africa Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 386. Africa Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 387. North America Blood Glucose Testing Sales, by Country K Units (2023-2028)
  • Table 388. North America Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 389. North America Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 390. North America Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 391. United States Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 392. United States Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 393. United States Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 394. Canada Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 395. Canada Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 396. Canada Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 397. Mexico Blood Glucose Testing Sales, by Type K Units (2023-2028)
  • Table 398. Mexico Blood Glucose Testing Sales, by Diabetes Type K Units (2023-2028)
  • Table 399. Mexico Blood Glucose Testing Sales, by End-User K Units (2023-2028)
  • Table 400. Blood Glucose Testing: by Type(USD/Units)
  • Table 401. Research Programs/Design for This Report
  • Table 402. Key Data Information from Secondary Sources
  • Table 403. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Glucose Testing: by Type USD Million (2017-2022)
  • Figure 5. Global Blood Glucose Testing: by Diabetes Type USD Million (2017-2022)
  • Figure 6. Global Blood Glucose Testing: by End-User USD Million (2017-2022)
  • Figure 7. South America Blood Glucose Testing Share (%), by Country
  • Figure 8. Asia Pacific Blood Glucose Testing Share (%), by Country
  • Figure 9. Europe Blood Glucose Testing Share (%), by Country
  • Figure 10. MEA Blood Glucose Testing Share (%), by Country
  • Figure 11. North America Blood Glucose Testing Share (%), by Country
  • Figure 12. Global Blood Glucose Testing: by Type K Units (2017-2022)
  • Figure 13. Global Blood Glucose Testing: by Diabetes Type K Units (2017-2022)
  • Figure 14. Global Blood Glucose Testing: by End-User K Units (2017-2022)
  • Figure 15. South America Blood Glucose Testing Share (%), by Country
  • Figure 16. Asia Pacific Blood Glucose Testing Share (%), by Country
  • Figure 17. Europe Blood Glucose Testing Share (%), by Country
  • Figure 18. MEA Blood Glucose Testing Share (%), by Country
  • Figure 19. North America Blood Glucose Testing Share (%), by Country
  • Figure 20. Global Blood Glucose Testing: by Type USD/Units (2017-2022)
  • Figure 21. Global Blood Glucose Testing share by Players 2022 (%)
  • Figure 22. Global Blood Glucose Testing share by Players (Top 3) 2022(%)
  • Figure 23. Global Blood Glucose Testing share by Players (Top 5) 2022(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 26. Medtronic (Ireland) Revenue: by Geography 2022
  • Figure 27. Menarini Diagnostics (Italy) Revenue, Net Income and Gross profit
  • Figure 28. Menarini Diagnostics (Italy) Revenue: by Geography 2022
  • Figure 29. Abaxis (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abaxis (United States) Revenue: by Geography 2022
  • Figure 31. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 33. ACON Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. ACON Laboratories, Inc. (United States) Revenue: by Geography 2022
  • Figure 35. AgaMatrix (Germany) Revenue, Net Income and Gross profit
  • Figure 36. AgaMatrix (Germany) Revenue: by Geography 2022
  • Figure 37. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Bayer (Germany) Revenue: by Geography 2022
  • Figure 39. Bio-Rad (United States) Revenue, Net Income and Gross profit
  • Figure 40. Bio-Rad (United States) Revenue: by Geography 2022
  • Figure 41. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. Roche (Switzerland) Revenue: by Geography 2022
  • Figure 43. LifeScan (United States) Revenue, Net Income and Gross profit
  • Figure 44. LifeScan (United States) Revenue: by Geography 2022
  • Figure 45. Global Blood Glucose Testing: by Type USD Million (2023-2028)
  • Figure 46. Global Blood Glucose Testing: by Diabetes Type USD Million (2023-2028)
  • Figure 47. Global Blood Glucose Testing: by End-User USD Million (2023-2028)
  • Figure 48. South America Blood Glucose Testing Share (%), by Country
  • Figure 49. Asia Pacific Blood Glucose Testing Share (%), by Country
  • Figure 50. Europe Blood Glucose Testing Share (%), by Country
  • Figure 51. MEA Blood Glucose Testing Share (%), by Country
  • Figure 52. North America Blood Glucose Testing Share (%), by Country
  • Figure 53. Global Blood Glucose Testing: by Type K Units (2023-2028)
  • Figure 54. Global Blood Glucose Testing: by Diabetes Type K Units (2023-2028)
  • Figure 55. Global Blood Glucose Testing: by End-User K Units (2023-2028)
  • Figure 56. South America Blood Glucose Testing Share (%), by Country
  • Figure 57. Asia Pacific Blood Glucose Testing Share (%), by Country
  • Figure 58. Europe Blood Glucose Testing Share (%), by Country
  • Figure 59. MEA Blood Glucose Testing Share (%), by Country
  • Figure 60. North America Blood Glucose Testing Share (%), by Country
  • Figure 61. Global Blood Glucose Testing: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Medtronic (Ireland)
  • Menarini Diagnostics (Italy)
  • Abaxis (United States)
  • Abbott Laboratories (United States)
  • ACON Laboratories, Inc. (United States)
  • AgaMatrix (Germany)
  • Bayer (Germany)
  • Bio-Rad (United States)
  • Roche (Switzerland)
  • LifeScan (United States)
Additional players considered in the study are as follows:
Ascensia (Switzerland) , Dexcom (United States) , Ypsomed (Switzerland) , B. Braun (Germany)
Select User Access Type

Key Highlights of Report


Jun 2023 201 Pages 87 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Blood Glucose Testing research Quantitative research analysis
Global Blood Glucose Testing research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Blood Glucose Testing Market are by type [Blood Glucose Meters, Continuous Glucose Monitoring Systems {Sensors, Transmitter}, Glucose Monitoring Strips and Lancets], by end use application [].
The Blood Glucose Testing Market is gaining popularity and expected to see strong valuation by 2028.
  • Growing Prevalence of Diabetes
  • Increasing Aging Population with Diabetes

Know More About Global Blood Glucose Testing research Report?

Have a Query? Click Here

Other Related Reports

Heart Health Products Comprehensive Study by Consumer Group (Child, Adult, Senior), Category (Heart Health Nutrition, Heart Disease Prone, Heart Health Care (Post Heart Operations)), Form (Capsules, ...
$ 3750
Emergency Eyewash System Comprehensive Study by Type (Plumbed, Self-contained, Faucet Integrated/Mounted Eyewashes, Others), Application (Factories, Labs, Others), Mounting (Wall Mount, Pedestal, Cab...
$ 3650
Pharma Intelligence Comprehensive Study by Type (Hardware, Software, Services), Application (Drug Discovery & Repurposing, Clinical Research Trial, Personalized Medicine, Others), Technology (Deep Le...
$ 3450
Multiple Sclerosis Treatment Comprehensive Study by Type (Immunomodulators (Ponesimod, Glatopa, Copaxone, Others), Immunosuppressant (Cladribine, Others), Corticosteroids (Prednisone, Methylprednisol...
$ 3750
IBS Treatment Comprehensive Study by Type (IBS-D, IBS-C, IBS-M), Application (Hospitals, Clinics, Research Laboratories), Drug (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Others), ...
$ 3450
Antibody Drug Conjugates Comprehensive Study by Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor), Technology (Cleavable Linker, Non-Cleavable Linker), Drugs Type (A...
$ 3450